scholarly journals Effective Information Provision About the Side Effects of Treatment for Malignant Lymphoma: Protocol of a Randomized Controlled Trial Using Video Vignettes (Preprint)

2018 ◽  
Author(s):  
Nanon Labrie ◽  
Sandra van Dulmen ◽  
Marie José Kersten ◽  
Hanneke JCM de Haes ◽  
Arwen H Pieterse ◽  
...  

BACKGROUND Informing patients with cancer about the possible implications of prospective treatment is a crucial yet challenging task. Unfortunately, patients’ recall of medical information is generally poor and their information needs are not met. Effective information giving entails that oncologists help patients understand and recall the implications of their treatment, meanwhile fostering a trusting physician-patient relationship. Communication strategies that are often suggested to be effective are structuring and tailoring (cognition-oriented) but also are oncologists’ expressions of caring or empathy (affect-oriented). OBJECTIVE The aim of this study is to provide evidence concerning the pathways linking physician communication to (improved) consultation outcomes for patients. More specifically, the aim is to determine the effects of information structuring and information tailoring, combined with physician caring, on information recall, satisfaction with information, and trust in the physician (primary objective) and on symptom distress (secondary objective). METHODS A randomized controlled trial, systematically testing the effects of information structuring and information tailoring, each combined with caring, in 2 video-vignette experiments (2×2 and 2×2×2 design). Using an online survey platform, participants will be randomly allocated (blinded) to 1 of 12 conditions in which they are asked to view a video vignette (intervention) in which an oncologist discusses a treatment plan for malignant lymphoma with a patient. The independent variables of interest are systematically varied across conditions. The outcome measures are assessed in a survey, using validated instruments. Study participants are (former) patients with cancer and their relatives recruited via online panels and patient organizations. This protocol discusses the trial design, including the video-vignette design, intervention pretesting, and a pilot study. RESULTS Data collection has now been completed, and preliminary analyses will be available in Spring 2019. A total of 470 participants completed the first part of the survey and were randomized to receive the intervention. CONCLUSIONS The results of the proposed trial will provide evidence concerning the pathways linking physician information, giving skills to (improved) consultation outcomes for patients. CLINICALTRIAL Netherlands Trial Register NTR6153; https://www.trialregister.nl/trial/6022 (Archived by Webcite at http://www.webcitation.org/76xVV9xC8). INTERNATIONAL REGISTERED REPOR DERR1-10.2196/12453

Cancer ◽  
2020 ◽  
Vol 126 (23) ◽  
pp. 5165-5172
Author(s):  
Vani N. Simmons ◽  
Steven K. Sutton ◽  
Lauren R. Meltzer ◽  
Ursula Martinez ◽  
Amanda M. Palmer ◽  
...  

2010 ◽  
Vol 40 (1) ◽  
pp. 49-59 ◽  
Author(s):  
Melanie R. Lovell ◽  
Peta M. Forder ◽  
Martin R. Stockler ◽  
Phyllis Butow ◽  
Esther M. Briganti ◽  
...  

1998 ◽  
Vol 1 (1) ◽  
pp. 50-61 ◽  
Author(s):  
Steven J. Bernstein ◽  
Kimberly A. Skarupski ◽  
Carla E. Grayson ◽  
Mark R. Starling ◽  
Eric R. Bates ◽  
...  

Author(s):  
Jason A. Webb ◽  
Arif H. Kamal

Palliative oxygen therapy is used for treating dyspnea in patients with cancer and advanced cardiopulmonary diseases, however, small trials have suggested that circulating air may be just as effective. This international, multicenter, randomized controlled trial compared oxygen versus room air delivered by a nasal cannula for relief of dyspnea for patients with any life-limiting illness. Patients were adults >18 years of age, with PaO2 > 7.3kPa, on optimized therapies for their illness, and an expected survival of >1 month. The study demonstrated no clinically significant symptomatic benefit of palliative oxygen versus room air delivered via nasal cannula for seven days in patients with life-limiting illnesses and refractory dyspnea.


PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0219065 ◽  
Author(s):  
Toshitaka Morishima ◽  
Isao Miyashiro ◽  
Norimitsu Inoue ◽  
Mitsuko Kitasaka ◽  
Takashi Akazawa ◽  
...  

2020 ◽  
pp. neurintsurg-2020-017025
Author(s):  
Cynthia B Zevallos ◽  
Mudassir Farooqui ◽  
Darko Quispe-Orozco ◽  
Alan Mendez-Ruiz ◽  
Mary Patterson ◽  
...  

BackgroundWhile mechanical thrombectomy (MT) is the standard of care for large vessel occlusion strokes, the optimal management of tandem occlusions (TO) remains uncertain. We aimed to determine the current practice patterns among stroke physicians involved in the treatment of TO during MT.MethodsWe distributed an online survey to neurovascular practitioners (stroke neurologists, neurointerventionalists, neurosurgeons, and radiologists), members of professional societies. After 2 months the site was closed and data were extracted and analyzed. We divided respondents into acute stenting and delayed treatment groups and responses were compared between the two groups.ResultsWe received 220 responses from North America (48%), Latin America (28%), Asia (15%), Europe (5%), and Africa (4%). Preferred timing for cervical revascularization varied among respondents; 51% preferred treatment in a subsequent procedure during the same hospitalization whereas 39% preferred to treat during MT. Angioplasty and stenting (41%) was the preferred technique, followed by balloon angioplasty and local aspiration (38%). The risk of intracerebral hemorrhage was the most compelling reason for not stenting acutely (68%). There were no significant differences among practice characteristics and timing groups. Most practitioners (70%) agreed that there is equipoise regarding the optimal endovascular treatment of cervical lesions in TO; hence, 77% would participate in a randomized controlled trial.ConclusionsThe PICASSO survey demonstrates multiple areas of uncertainty regarding the medical and endovascular management of TOs. Experts acknowledged the need for further evidence and their willingness to participate in a randomized controlled trial to evaluate the best treatment for the cervical TO lesion.


Sign in / Sign up

Export Citation Format

Share Document